Eledon Pharmaceuticals, Inc. (ELDN)
2.99
-0.02
(-0.66%)
USD |
NASDAQ |
Sep 02, 16:00
2.985
0.00 (0.00%)
After-Hours: 20:00
Eledon Pharmaceuticals Cash from Operations (Annual) : -62.34M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -62.34M |
| December 31, 2024 | -47.27M |
| December 31, 2023 | -39.53M |
| December 31, 2022 | -28.42M |
| December 31, 2021 | -28.91M |
| December 31, 2020 | -15.21M |
| December 31, 2019 | -13.86M |
| Date | Value |
|---|---|
| December 31, 2018 | -11.89M |
| December 31, 2017 | -14.94M |
| December 31, 2016 | -4.923M |
| December 31, 2015 | -41.24M |
| December 31, 2014 | -21.12M |
| December 31, 2013 | -15.48M |
| December 31, 2012 | -9.333M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.631B |
| Viking Therapeutics, Inc. | -278.68M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Anika Therapeutics, Inc. | 11.19M |